Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study
PaperCitations, authors & open-access status
Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: Results of the randomized phase 3 CADMUS study is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 228 citations, 2015 year and hybrid oa status.
228
Citations
2015
Year
hybrid
OA Status